Tenaya Therapeutics (TNYA) Stock Highlights

1.67 | +18.44%

2024-12-21 06:16:55

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.

Statistics

Range Today

1.35 1.67

Volume Today 9.57M

Range 1 Year

0.99 7.01

Volume 1 Year 347.56M

Range 3 Year

0.99 22.87

Volume 3 Year 501.79M

Range 10 Year

0.99 32

Volume 10 Year 520.75M

Highlights

Market Capitalization 217.73M (small)

Floating Shares 59.2M

Current Price 1.67

Price To Earnings -1.89

Price To Book 2.11

Earnings Per Share -1.59

Payout Ratio 0%

Performance

Latest +18.44%

1 Month -31.84%

3 Months -21.23%

6 Months -47.15%

1 Year -34.77%

3 Years -91.37%

5 Years -91.44%

10 Years -91.44%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.